Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin

BACKGROUND: Rifampicin lowers nevirapine plasma concentrations by inducing cytochrome P450. However, few data are available on this interaction during the lead-in period of nevirapine treatment. METHODS: Eighteen HIV-1/tuberculosis co-infected adults receiving rifampicin daily as part of anti-tuberc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lamorde, Mohammed, Byakika-Kibwika, Pauline, Okaba-Kayom, Violet, Ryan, Mairin, Coakley, Peter, Boffito, Marta, Namakula, Rhoda, Kalemeera, Francis, Colebunders, Robert, Back, David, Khoo, Saye, Merry, Concepta
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2011
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3001850/
https://ncbi.nlm.nih.gov/pubmed/21047828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkq411
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars